Search company, investor...

Immutrix Therapeutics

immutrix.com

Stage

Unattributed - IV | Alive

Total Raised

$13.3M

Last Raised

$300K | 2 yrs ago

About Immutrix Therapeutics

ImmutriX Therapeutics develops a medical device for cleansing whole blood to modulate and sequester molecules from circulation known to be contrary to health. ImmutriX products target and bind molecules ("modifiers") of interest in a "dialysis-like" procedure to treat a broad range of medical conditions. The Modifiers to be removed are those molecules which cause an undesired immune or pathological response, often referred to as mediators.

Headquarters Location

3620 Homestead Street

Rapid City, South Dakota, 57703,

United States

605-721-7979

Missing: Immutrix Therapeutics's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Immutrix Therapeutics's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Immutrix Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Immutrix Therapeutics is included in 2 Expert Collections, including Medical Devices.

M

Medical Devices

8,560 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health IT

7,901 items

Immutrix Therapeutics Patents

Immutrix Therapeutics has filed 1 patent.

The 3 most popular patent topics include:

  • Animal viral diseases
  • Biological weapons
  • Hemorrhagic fevers
patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/27/2016

2/22/2022

Transfusion medicine, Clusters of differentiation, Blood, Immune system, Immunology

Grant

Application Date

5/27/2016

Grant Date

2/22/2022

Title

Related Topics

Transfusion medicine, Clusters of differentiation, Blood, Immune system, Immunology

Status

Grant

Immutrix Therapeutics Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Immutrix Therapeutics Rank

Immutrix Therapeutics Frequently Asked Questions (FAQ)

  • Where is Immutrix Therapeutics's headquarters?

    Immutrix Therapeutics's headquarters is located at 3620 Homestead Street, Rapid City.

  • What is Immutrix Therapeutics's latest funding round?

    Immutrix Therapeutics's latest funding round is Unattributed - IV.

  • How much did Immutrix Therapeutics raise?

    Immutrix Therapeutics raised a total of $13.3M.

  • Who are the investors of Immutrix Therapeutics?

    Investors of Immutrix Therapeutics include Paycheck Protection Program.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.